TY - JOUR T1 - Cost-effectiveness of combination nonbiologic disease-modifying antirheumatic drug strategies in patients with early rheumatoid arthritis. JO - J Rheumatol PY - 2011/01/01 AU - Tosh JC AU - Wailoo AJ AU - Scott DL AU - Deighton CM ED - DO - DOI: 10.3899/jrheum.101327 VL - 38 IS - 8 SP - 1593 EP - 1600 Y2 - 2025/08/11 ER -